OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| OSUR | ORASURE TECHNOLOGIES INC | 2026-10-15 14:34:22 | 3.83 | 0.1 | 2.55 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OSUR | 0001116463 | ORASURE TECHNOLOGIES INC | US68554V1089 | 529900GNNJPNM4XHXQ77 | 364370966 | Nasdaq | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | DE | 220 E FIRST ST | BETHLEHEM | PA | 18015 | UNITED STATES | US | 5036416115 | 220 E FIRST ST, BETHLEHEM, PA, 18015 | 220 E FIRST ST, BETHLEHEM, PA, 18015 | — | Medical Devices | — | — | — | — | 218,472,693 | 68,968,000 | 68,968,627 | OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. | 2026-10-09 04:03:46 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 218,472,693 | -96,362,343 | -30.6072 | 69,126,173 | -5,673,958 | -7.5855 |
| 2024 | 314,835,036 | -53,458,636 | -14.5152 | 74,800,131 | 1,003,863 | 1.3603 |
| 2023 | 368,293,672 | 170,549,980 | 86.248 | 73,796,268 | 551,461 | 0.7529 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Kathleen G. Weber | Chief Product Officer | 2025 | 421,145 | 0 | 647,020 | 0 | 768,270 | 1,836,435 |
| Kenneth Mcgrath | Chief Financial Officer | 2025 | 512,000 | 0 | 738,768 | 61,440 | 4,000 | 1,316,208 |
| Carrie Eglinton Manner | Chief Executive Officer, President | 2025 | 721,000 | 0 | 3,394,188 | 173,040 | 4,000 | 4,292,228 |
| Carrie Eglinton Manner | Chief Executive Officer, President | 2024 | 721,000 | 0 | 4,187,301 | 689,997 | 4,000 | 5,602,298 |
| Kathleen G. Weber | Chief Product Officer | 2024 | 488,000 | 0 | 661,309 | 233,508 | 14,921 | 1,397,738 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 500 |
| 2024 | 501 |
| 2023 | 638 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 115,021,000 | 185,827,000 | 405,472,000 |
| Cost Of Revenue | 66,823,000 | 106,437,000 | 233,820,000 |
| Gross Profit | 48,198,000 | 79,390,000 | 171,652,000 |
| Research And Development Expenses | 42,528,000 | 26,047,000 | 33,728,000 |
| General And Administrative Expenses | 47,677,000 | 46,215,000 | 58,191,000 |
| Operating Expenses | 120,167,000 | 107,640,000 | 138,968,000 |
| Operating Income | -71,969,000 | -28,250,000 | 32,684,000 |
| Net Income | -68,731,000 | -19,500,000 | 53,655,000 |
| Earnings Per Share Basic | -0.94 | -0.26 | 0.73 |
| Earnings Per Share Diluted | -0.94 | -0.26 | 0.72 |
| Weighted Average Shares Outstanding Basic | 73,485,000 | 74,434,000 | 73,348,000 |
| Weighted Average Shares Outstanding Diluted | 73,485,000 | 74,434,000 | 74,389,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 199,278,000 | 267,763,000 | 290,407,000 |
| Marketable Securities Current | — | — | 0 |
| Accounts Receivable | 22,203,000 | 23,816,000 | 40,171,000 |
| Inventories | 31,060,000 | 34,197,000 | 47,614,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 4,146,000 | 3,488,000 | 2,226,000 |
| Total Assets Current | 261,908,000 | 333,220,000 | 386,459,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 39,179,000 | 45,105,000 | 45,420,000 |
| Other Assets Non Current | 1,303,000 | 1,526,000 | 1,218,000 |
| Total Assets Non Current | 51,321,000 | 58,692,000 | 58,266,000 |
| Total Assets | 403,168,000 | 479,659,000 | 482,845,000 |
| Accounts Payable | 6,521,000 | 8,173,000 | 13,151,000 |
| Deferred Revenue | 1,518,000 | 3,000,000 | 1,200,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | — | — | — |
| Total Liabilities Current | 39,795,000 | 33,483,000 | 39,536,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 2,243,000 | 494,000 | 696,000 |
| Total Liabilities Non Current | 22,546,000 | 35,838,000 | 12,638,000 |
| Total Liabilities | 62,341,000 | 69,321,000 | 52,174,000 |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | -172,162,000 | -103,431,000 | -83,931,000 |
| Accumulated Other Comprehensive Income | -18,404,000 | -24,360,000 | -14,941,000 |
| Total Shareholders Equity | 340,827,000 | 410,338,000 | 430,671,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 10,192,000 | 10,872,000 | 20,936,000 |
| Share Based Compensation Expense | 10,147,000 | 11,920,000 | 10,729,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -1,949,000 | -15,872,000 | -31,116,000 |
| Change In Inventories | -3,562,000 | -13,096,000 | -48,228,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 2,368,000 | -4,089,000 | 2,499,000 |
| Change In Accounts Payable | -1,720,000 | -7,577,000 | -26,976,000 |
| Change In Other Liabilities | -8,663,000 | -6,443,000 | -3,384,000 |
| Cash From Operating Activities | -49,023,000 | 27,374,000 | 141,583,000 |
| Purchases Of Marketable Securities | 0 | 53,244,000 | 74,652,000 |
| Sales Of Marketable Securities | 0 | 53,052,000 | 102,440,000 |
| Acquisition Of Property Plant And Equipment | 4,197,000 | 3,797,000 | 5,802,000 |
| Acquisition Of Business | 3,613,000 | 5,037,000 | — |
| Other Investing Activities | — | — | 0 |
| Cash From Investing Activities | -6,810,000 | -39,026,000 | 66,154,000 |
| Tax Withholding For Share Based Compensation | 1,843,000 | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | 214,000 | 269,000 |
| Repurchase Of Common Stock | 15,040,000 | 3,548,000 | 1,901,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -16,944,000 | -4,176,000 | -3,023,000 |
| Change In Cash | -68,485,000 | -22,644,000 | 206,427,000 |
| Cash At End Of Period | 199,278,000 | 267,763,000 | 290,407,000 |
| Income Taxes Paid | 1,800,000 | 1,800,000 | — |
| Interest Paid | — | 22,000 | 51,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -0.94 | -0.26 | 0.73 |
| Price To Earnings Ratio | -2.5745 | -13.8846 | 11.2329 |
| Earnings Growth Rate | 261.5385 | -135.6164 | -392 |
| Price Earnings To Growth Ratio | -0.0098 | 0.1024 | -0.0287 |
| Book Value Per Share | 4.638 | 5.5128 | 5.8716 |
| Price To Book Ratio | 0.5218 | 0.6548 | 1.3966 |
| Ebitda | -56,739,000 | -6,828,000 | 74,591,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 4,266,000 | 10,557,000 | 6,943,000 |
| Free Cash Flow | -53,289,000 | 16,817,000 | 134,640,000 |
| Return On Equity | -0.2017 | -0.0475 | 0.1246 |
| One Year Beta | 1.1436 | 0.9924 | 1.0554 |
| Three Year Beta | 1.0852 | 1.1365 | 1.0109 |
| Five Year Beta | 1.0384 | 0.808 | 0.8438 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Boyd Steven Kyle | Director | 2026-09-29 | 4,797 | A | 168,031 |
| Kenny John P. | Director | 2026-09-06 | 5,116 | D | 204,598 |
| Boyd Steven Kyle | Director | 2026-06-26 | 3,666 | A | 163,234 |
| Bertrand John D. | Director | 2026-06-03 | 46,106 | A | 79,767 |
| Gagliano Nancy J | Director | 2026-06-03 | 46,106 | A | 185,055 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Blue Trust, Inc. | 2026-09-30 | 992 | 253 | 3.9209 |
| Essential Partners LLC | 2026-09-30 | 757 | 193 | 3.9223 |
| CGC Financial Services, LLC | 2026-09-30 | 7,209 | 1,839 | 3.9201 |
| True Wealth Design, LLC | 2026-09-30 | 55 | 14 | 3.9286 |
| Farther Finance Advisors, LLC | 2026-09-30 | 10,772 | 2,748 | 3.9199 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 2026-08-31 | Column Small Cap Fund | CFSLX | 36,242 | 130,108.78 | 0.0239 |
| TRUST FOR PROFESSIONAL MANAGERS | 2026-08-31 | Column Small Cap Select Fund | CFSSX | 241,719 | 867,771.21 | 0.0453 |
| VICTORY PORTFOLIOS III | 2026-07-31 | Victory Extended Market Index Fund | USMIX | 7,490 | 30,334.5 | 0.0037 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-07-31 | Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 74,228 | 300,623.4 | 0.0109 |
| Global X Funds | 2026-07-31 | Global X Russell 2000 ETF | RSSL | 31,322 | 126,854.1 | 0.0085 |